Artificial Intelligence (AI) In Drug Discovery Global Market To Grow At Rate Of 30% Through 2026

The Business Research Company's Artificial Intelligence (AI) In Drug Discovery Global Market Report 2022 –Market Size, Trends, And Global Forecast 2022-2026

LONDON, GREATER LONDON, UK, January 20, 2022 /EINPresswire.com/ -- According to ‘Artificial Intelligence (AI) In Drug Discovery Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026’ published by The Business Research Company, the artificial intelligence in drug discovery market size is expected to grow from $791.83 million in 2021 to $1042.30 million in 2022 at a compound annual growth rate (CAGR) of 31.6%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The AI in drug discovery market is expected to reach $2994.52 million in 2026 at a CAGR of 30.2%. The rise in demand for a reduction in the overall time taken for the drug discovery process is a key driver propelling the artificial intelligence in drug discovery market growth.

Want to learn more on the artificial intelligence (AI) in drug discovery market growth? Request for a Sample now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3411&type=smp

The artificial intelligence in drug discovery market consists of sales of AI for drug discovery and related services. AI for drug discovery is a technology that uses a simulation of human intelligence process by machines to tackle complex problems in the drug discovery process. It helps to find new molecules to identify drug targets and develop personalized medicines in the pharmaceutical industry.

Global Artificial Intelligence (AI) In Drug Discovery Market Trends
Major companies operating in the AI drug delivery market are adopting strategic collaborations to research and discover drugs using AI and are gaining significant popularity in the artificial intelligence in drug discovery market.

Global Artificial Intelligence (AI) In Drug Discovery Market Segments
The global artificial intelligence in drug discovery market is segmented:
By Technology: Deep Learning, Machine Learning
By Drug Type: Small Molecule, Large Molecules
By Disease Type: Metabolic Disease, Cardiovascular Disease, Oncology, Neurodegenerative Diseases, Others
By End-Users: Pharmaceutical Companies, Biopharmaceutical Companies, Academic and Research Institutes, Others
By Geography: The global AI in drug discovery market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Read more on the global artificial intelligence (AI) in drug discovery market report at:
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-drug-discovery-global-market-report

Artificial Intelligence (AI) In Drug Discovery Global Market Report 2022 is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI) in drug discovery market insights, artificial intelligence (AI) in drug discovery market analysis, forecasts market size and growth for the global artificial intelligence (AI) in drug discovery market, artificial intelligence (AI) in drug discovery market share, artificial intelligence (AI) in drug discovery market segments and geographies, artificial intelligence (AI) in drug discovery market trends, artificial intelligence (AI) in drug discovery market players, leading competitor revenues, profiles and market shares. The artificial intelligence (AI) in drug discovery market report identifies top countries and segments for opportunities and strategies based on market trends and key competitors’ approaches.

TBRC’s Artificial Intelligence (AI) In Drug Discovery Global Market Report 2022 includes information on the following:
Data Segmentations: Market Size, Global, By Region and Country, Historic and Forecast, and Growth Rates for 60 Geographies

Key Market Players: IBM Corporation, Microsoft, Atomwise Inc., Deep Genomics, Cloud Pharmaceuticals, Insilico Medicine, Benevolent AI, Exscientia, Cyclica and BIOAGE.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
And so much more.

Looking for something else? Here is a list of similar reports by The Business Research Company:
AI In Pharma Global Market Report 2021
https://www.thebusinessresearchcompany.com/report/ai-in-pharma-global-market-report

Artificial Intelligence Global Market Report 2021
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-market-global-report-2020-30-covid-19-growth-and-change

Artificial Intelligence Services Global Market Report 2021
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-services-market-global-report-2020-30-covid-19-growth-and-change

About The Business Research Company
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Check out our:
LinkedIn: https://bit.ly/3b7850r
Twitter: https://bit.ly/3b1rmjS
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: http://blog.tbrc.info/

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn